These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1323551)

  • 1. Evaluation of CHIP (iproplatin) in recurrent pediatric malignant solid tumors. A phase II study (Pediatric Oncology Group).
    Nitschke R; Pratt C; Harris M; Krischer J; Vietti TJ; Grier H; Kamps W; Toledano S
    Invest New Drugs; 1992 Jul; 10(2):93-6. PubMed ID: 1323551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of iproplatin (CHIP) in patients with cisplatin-refractory germ cell tumors; the need for alternative strategies in the investigation of new agents in GCT.
    Murphy BA; Motzer RJ; Bosl GJ
    Invest New Drugs; 1992 Nov; 10(4):327-30. PubMed ID: 1336770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II study.
    Friedman HS; Krischer JP; Burger P; Oakes WJ; Hockenberger B; Weiner MD; Falletta JM; Norris D; Ragab AH; Mahoney DH
    J Clin Oncol; 1992 Feb; 10(2):249-56. PubMed ID: 1732426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II evaluation of iproplatin in refractory germ cell tumors: a Southeastern Cancer Study Group trial.
    Drasga RE; Williams SD; Einhorn LH; Birch R
    Cancer Treat Rep; 1987 Sep; 71(9):863-4. PubMed ID: 3040247
    [No Abstract]   [Full Text] [Related]  

  • 5. A phase II trial of iproplatin (CHIP) in previously treated advanced breast cancer.
    Meisner DJ; Ginsberg S; Ditch A; Louie A; Newman N; Comis R; Poiesz B
    Am J Clin Oncol; 1989 Apr; 12(2):129-31. PubMed ID: 2705402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I--preliminary phase II trial of iproplatin, a cisplatin analogue.
    Paolozzi FP; Gaver R; Poiesz BJ; Louie A; DiFino S; Comis RL; Newman N; Ginsberg S
    Invest New Drugs; 1988 Sep; 6(3):199-206. PubMed ID: 3192385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II investigational window using carboplatin, iproplatin, ifosfamide, and epirubicin in children with untreated disseminated neuroblastoma: a Pediatric Oncology Group study.
    Castleberry RP; Cantor AB; Green AA; Joshi V; Berkow RL; Buchanan GR; Leventhal B; Mahoney DH; Smith EI; Hayes FA
    J Clin Oncol; 1994 Aug; 12(8):1616-20. PubMed ID: 8040674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical development of iproplatin (CHIP).
    Creaven PJ; Pendyala L; Madajewicz S
    Drugs Exp Clin Res; 1986; 12(1-3):287-92. PubMed ID: 3732051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of iproplatin (CHIP, JM-9) in advanced testicular cancers progressing after prior chemotherapy.
    Clavel M; Monfardini S; Gundersen S; Kaye S; Siegenthaler P; Renard J; van Glabbeke M; Pinedo HM
    Eur J Cancer Clin Oncol; 1988 Aug; 24(8):1345-8. PubMed ID: 3181255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of weekly-administered iproplatin [cis-dichloro-trans-dihydroxy-bis-isopropylamine platin (chip, JM9)].
    Chawla SP; Yap BS; Tenney DM; Bodey GP; Benjamin RS
    Invest New Drugs; 1988 Dec; 6(4):311-7. PubMed ID: 3229943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of iproplatin in advanced ovarian carcinoma.
    Sessa C; Vermorken J; Renard J; Kaye S; Smith D; ten Bokkel Huinink W; Cavalli F; Pinedo H
    J Clin Oncol; 1988 Jan; 6(1):98-105. PubMed ID: 3335895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study.
    McGuire WP; Arseneau J; Blessing JA; DiSaia PJ; Hatch KD; Given FT; Teng NN; Creasman WT
    J Clin Oncol; 1989 Oct; 7(10):1462-8. PubMed ID: 2674333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study.
    Blaney SM; Needle MN; Gillespie A; Sato JK; Reaman GH; Berg SL; Adamson PC; Krailo MD; Bleyer WA; Poplack DG; Balis FM
    Clin Cancer Res; 1998 Feb; 4(2):357-60. PubMed ID: 9516923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of iproplatin in pediatric patients: a Pediatric Oncology Group Study.
    Pratt CB; Kamen BA; Winick N; Sartain P; Champion JE; Ragab AH; Goren MP
    Cancer Treat Rep; 1987 Jan; 71(1):87-8. PubMed ID: 3791272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: a Children's Oncology Group study.
    Beaty O; Berg S; Blaney S; Malogolowkin M; Krailo M; Knight R; Schaiquevich P; Stewart C; Chen Z; Nelson M; Voss S; Ivy SP; Adamson PC
    Pediatr Blood Cancer; 2010 Sep; 55(3):440-5. PubMed ID: 20658614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-line treatment of advanced measurable ovarian cancer with iproplatin: a Southwest Oncology Group study.
    Weiss G; Green S; Alberts DS; Thigpen JT; Hines HE; Hanson K; Pierce HI; Baker LH; Goodwin JW
    Eur J Cancer; 1991; 27(2):135-8. PubMed ID: 1827275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of carboplatin in patients with advanced germ cell tumors refractory to cisplatin.
    Motzer RJ; Bosl GJ; Tauer K; Golbey R
    Cancer Treat Rep; 1987 Feb; 71(2):197-8. PubMed ID: 3026627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized phase II trial of iproplatin and carboplatin in advanced breast cancer. The EORTC Early Clinical Trials Group and the EORTC Data Center.
    Vermorken JB; Gundersen S; Clavel M; Smyth JF; Dodion P; Renard J; Kaye SB
    Ann Oncol; 1993 Apr; 4(4):303-6. PubMed ID: 8518220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of CHIP chemotherapy in advanced adenocarcinomas of the upper gastrointestinal tract.
    Goldenberg AS; Kelsen D; Dougherty J; Magill G
    Invest New Drugs; 1990 Feb; 8(1):71-5. PubMed ID: 2345073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I study of carboplatin (CBDCA) in children with cancer.
    Bacha DM; Caparros-Sison B; Allen JA; Walker R; Tan CT
    Cancer Treat Rep; 1986 Jul; 70(7):865-9. PubMed ID: 3521846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.